Haemonetics stock hits 52-week low at $70.1 amid challenges
In a year marked by volatility, Haemonetics Corp (NYSE: NYSE:HAE) stock has touched a 52-week low, reaching a price level of $70.1. The company maintains a strong financial position with a "GOOD" ...
Haemonetics stock touches 52-week low at $69.2 amid challenges
Haemonetics Corporation (NYSE:HAE), a global healthcare company with a market capitalization of $3.48 billion, has seen its stock price touch a 52-week low, reaching $69.2. According to InvestingPro ...
Yahoo Finance22d
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...
Business Insider19d
Citi Reaffirms Their Hold Rating on Haemonetics (HAE)
In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics (HAE – Research Report). The company’s shares closed yesterday at $75.05. Discover outperforming ...